{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:15:50Z","timestamp":1786986950402,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cmi.2024.08.022","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T16:50:00Z","timestamp":1725036600000},"page":"1529-1536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["How do I manage disseminated Mycobacterium avium complex disease in people with HIV?"],"prefix":"10.1016","volume":"30","author":[{"given":"Tommaso","family":"Matucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Pozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Roberto","family":"Raccagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Borghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Nozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2024.08.022_bib1","article-title":"HIV late presenters in Asia: management and public health challenges","volume":"2023","author":"Wong","year":"2023","journal-title":"AIDS Res Treat"},{"key":"10.1016\/j.cmi.2024.08.022_bib2","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/QAD.0000000000003924","article-title":"Care interruptions and mortality among adults in Europe and North America","volume":"38","author":"Trickey","year":"2024","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2024.08.022_bib3","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/QAD.0000000000003859","article-title":"The effect of care interruptions on mortality in adults resuming antiretroviral therapy","volume":"38","author":"Moolla","year":"2024","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2024.08.022_bib4","doi-asserted-by":"crossref","first-page":"9632","DOI":"10.1038\/s41598-021-88367-5","article-title":"Determinants of loss to care and risk of clinical progression in PLWH who are re-engaged in care after a temporary loss","volume":"11","author":"Mussini","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2024.08.022_bib5","series-title":"HIV\/AIDS surveillance in Europe 2023\u20132022 data","year":"2023"},{"key":"10.1016\/j.cmi.2024.08.022_bib6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/cid\/cix915","article-title":"Global trends in CD4 cell count at the start of antiretroviral therapy: collaborative study of treatment programs","volume":"66","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.08.022_bib7","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/cid\/ciy045","article-title":"Persistent high burden of advanced HIV disease among patients seeking care in South Africa's National HIV Program: data from a Nationwide Laboratory Cohort","volume":"66","author":"Carmona","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.08.022_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.106995","article-title":"Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis \u2013 results from the ICONA cohort in Italy, 2009-2022","volume":"142","author":"Mondi","year":"2024","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2024.08.022_bib9","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/infdis\/165.6.1082","article-title":"Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients","volume":"165","author":"Nightingale","year":"1992","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2024.08.022_bib10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1473-3099(04)01130-2","article-title":"Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy","volume":"4","author":"Karakousis","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2024.08.022_bib11","volume":"35","author":"Regine","year":"2022"},{"key":"10.1016\/j.cmi.2024.08.022_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/hiv.12403","article-title":"The late-presenting HIV-infected patient 30 years after the introduction of HIV testing: spectrum of opportunistic diseases and missed opportunities for early diagnosis","volume":"18","author":"Tominski","year":"2017","journal-title":"HIV Med"},{"key":"10.1016\/j.cmi.2024.08.022_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151682","article-title":"High mortality of disseminated non-tuberculous Mycobacterial infection in HIV-infected patients in the antiretroviral therapy era","volume":"11","author":"Kobayashi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2024.08.022_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(05)78279-9","article-title":"Effect of HAART on natural history of AIDS-related opportunistic disorders","volume":"351","author":"Sepkowitz","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2024.08.022_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-133-6-200009190-00013","article-title":"Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy","volume":"133","author":"DeSimone","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2024.08.022_bib16","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/497269","article-title":"Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up","volume":"41","author":"Phillips","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.08.022_bib17","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1089\/aid.2017.0030","article-title":"Short Communication: Mycobacterium avium complex infection and immune reconstitution inflammatory syndrome remain a challenge in the era of effective antiretroviral therapy","volume":"33","author":"Smibert","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.cmi.2024.08.022_bib18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/infdis\/161.4.801","article-title":"Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients","volume":"161","author":"Hoy","year":"1990","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2024.08.022_bib19","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/jcm.31.7.1811-1814.1993","article-title":"Diagnosis of Mycobacterium avium bacteremia by polymerase chain reaction","volume":"31","author":"Iralu","year":"1993","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2024.08.022_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1099\/jmm.0.46298-0","article-title":"Diagnostic application of genotypic identification of mycobacteria","volume":"55","author":"Yam","year":"2006","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.cmi.2024.08.022_bib21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/jcp.41.6.687","article-title":"Comparison of methods for isolating Mycobacterium avium-intracellulare from blood of patients with AIDS","volume":"41","author":"Shanson","year":"1988","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cmi.2024.08.022_bib22","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajcp\/110.6.806","article-title":"Detecting disseminated Mycobacterium avium complex infections in HIV-positive patients. The usefulness of bone marrow trephine biopsy specimens, aspirate cultures, and blood cultures","volume":"110","author":"Hussong","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cmi.2024.08.022_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0033-1333569","article-title":"Diagnosis of nontuberculous mycobacterial infections","volume":"34","author":"van Ingen","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2024.08.022_bib24","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cmi.2023.02.007","article-title":"Towards clinical breakpoints for non-tuberculous mycobacteria \u2013 determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution","volume":"29","author":"Fr\u00f6berg","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.08.022_bib25","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.21037\/apm-21-1205","article-title":"The value of gene chip detection of bronchoalveolar lavage fluid in the diagnosis of nontuberculous mycobacterial lung disease","volume":"10","author":"Huang","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.cmi.2024.08.022_bib26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0009-9260(98)80192-X","article-title":"Frequency of abdominal CT findings in AIDS patients with M.\u00a0avium complex bacteraemia","volume":"53","author":"Pantongrag-Brown","year":"1998","journal-title":"Clin Radiol"},{"key":"10.1016\/j.cmi.2024.08.022_bib27","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciaa1125","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA Clinical Practice Guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.08.022_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1513\/AnnalsATS.201308-266OC","article-title":"Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study","volume":"11","author":"Miwa","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.cmi.2024.08.022_bib30","first-page":"8","article-title":"High overall mortality of Mycobacterium genavense infections and impact of antimycobacterial therapy: systematic review and individual patient data meta-analysis","volume":"84","author":"Wetzstein","year":"2022","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2024.08.022_bib31","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1164\/rccm.200603-450OC","article-title":"Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease","volume":"174","author":"Griffith","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2024.08.022_bib32","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1086\/514748","article-title":"A\u00a0randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex","volume":"28","author":"Gordin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.08.022_bib33","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1086\/378807","article-title":"A\u00a0prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome","volume":"37","author":"Benson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.08.022_bib34","doi-asserted-by":"crossref","first-page":"905","DOI":"10.7326\/0003-4819-121-12-199412150-00001","article-title":"Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team","volume":"121","author":"Chaisson","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2024.08.022_bib35","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1086\/317468","article-title":"A\u00a0randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus","volume":"31","author":"Dunne","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.08.022_bib36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM199608083350602","article-title":"A\u00a0comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group","volume":"335","author":"Shafran","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2024.08.022_bib39","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1128\/AAC.02281-12","article-title":"Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen","volume":"57","author":"Koh","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.08.022_bib40","article-title":"Role of clofazimine in treatment of Mycobacterium avium complex","volume":"8","author":"Nasiri","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.cmi.2024.08.022_bib41","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1183\/23120541.00466-2021","article-title":"Treatment of severe Mycobacterium avium complex pulmonary disease with adjunctive amikacin and clofazimine versus standard regimen alone: a retrospective study","volume":"7","author":"Zweijpfenning","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.cmi.2024.08.022_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1574891X12666170619101904","article-title":"Bedaquiline: a new hope for shorter and better anti-tuberculosis regimens","volume":"13","author":"Riccardi","year":"2018","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"10.1016\/j.cmi.2024.08.022_bib43","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/infdis\/jiaa669","article-title":"Clinical and immunologic predictors of Mycobacterium avium complex immune reconstitution inflammatory syndrome in a contemporary cohort of patients with human immunodeficiency virus","volume":"223","author":"Breglio","year":"2021","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2024.08.022_bib44","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1128\/AAC.38.9.2215","article-title":"Low-dose dexamethasone as adjunctive therapy for disseminated Mycobacterium avium complex infections in AIDS patients","volume":"38","author":"Wormser","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.08.022_bib47","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/jac\/dkv470","article-title":"Population pharmacokinetic drug-drug interaction pooled analysis of existing data for rifabutin and HIV PIs","volume":"71","author":"Hennig","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2024.08.022_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/2050-6511-15-61","article-title":"Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV-infected tuberculosis patients on lopinavir\/ritonavir-based antiretroviral therapy","volume":"15","author":"Naiker","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.cmi.2024.08.022_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/QAI.0b013e318276cda9","article-title":"Safety, tolerability, and pharmacokinetics of the HIV integrase inhibitor dolutegravir given twice daily with rifampin or once daily with rifabutin: results of a phase 1 study among healthy subjects","volume":"62","author":"Dooley","year":"2013","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cmi.2024.08.022_bib50","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1177\/0091270010375959","article-title":"Lack of a clinically meaningful pharmacokinetic effect of rifabutin on raltegravir: In\u00a0vitro\/in\u00a0vivo correlation","volume":"51","author":"Brainard","year":"2011","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.cmi.2024.08.022_bib51","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/jac\/dkz068","article-title":"Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamide","volume":"74","author":"Cerrone","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2024.08.022_bib52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12931-024-02752-y","article-title":"Variables associated with antibiotic treatment tolerance in patients with Mycobacterium avium complex pulmonary disease","volume":"25","author":"Marmor","year":"2024","journal-title":"Respir Res"},{"key":"10.1016\/j.cmi.2024.08.022_bib53","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-133-7-200010030-00008","article-title":"Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count: a randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team","volume":"133","author":"Currier","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2024.08.022_bib54","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1089\/apc.2013.0270","article-title":"Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells\/\u03bcL who are virologically suppressed on cART?","volume":"28","author":"Yangco","year":"2014","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.cmi.2024.08.022_bib55","first-page":"797","article-title":"Cohort profile: collaboration of observational HIV epidemiological research Europe (COHERE) in EuroCoord","volume":"46","author":"Ch\u00eane","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.cmi.2024.08.022_bib56","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1086\/314469","article-title":"Eradication of AIDS-related disseminated Mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy","volume":"178","author":"Aberg","year":"1998","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2024.08.022_bib57","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02210-2023","article-title":"Rifampicin has no role in treatment of Mycobacterium avium complex pulmonary disease and bactericidal sterilising drugs are needed: a viewpoint","volume":"63","author":"van Ingen","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2024.08.022_bib58","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1164\/rccm.201204-0682OC","article-title":"The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment","volume":"186","author":"van Ingen","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2024.08.022_bib59","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.chest.2023.11.038","article-title":"Safety and efficacy of clofazimine as an alternative for rifampicin in Mycobacterium avium complex pulmonary disease treatment: outcomes of a randomized trial","volume":"16","author":"Zweijpfenning","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2024.08.022_bib60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/jac\/dkad372","article-title":"Bedaquiline for treatment of non-tuberculous mycobacteria (NTM): a systematic review and meta-analysis","volume":"79","author":"Omar","year":"2024","journal-title":"J\u00a0Antimicrob Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2400421X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2400421X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T01:09:48Z","timestamp":1764551388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X2400421X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1198743X2400421X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2024.08.022","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How do I manage disseminated Mycobacterium avium complex disease in people with HIV?","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2024.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}